The Weekend to Women's Cancers
The walkers, crew, volunteers, supporters and donors of The Shoppers Drug Mart® Weekend to End Women’s Cancers™ throughout the years are extremely important to breast and gynecologic cancer work at The Princess Margaret. All funds raised for The Weekend are advancing Personalized Cancer Medicine in critical areas such as:
- $50.5 million to The Campbell Family Institute for Breast Cancer Research led by Dr. Tak Mak, with 11 Principal Investigators and over
- Fundraising by Weekend walkers and donors has supported the following:
- Dr. Tak Mak and his team of researchers from The Campbell Family Research Institute announced a new “sharpshooter” cancer drug that will target an enzyme called PLK4, which plays a crucial role in the process of cancer cell division. On July 18, Dr. Mak and his team gained clearance by Health Canada to proceed with the drug into Phase I Clinical Trial in Canada.*
- Scientists led by Drs. Mona Gauthier and Tak Mak have discovered how BRCA1 gene mutations specifically predispose women to breast and ovarian cancers.
- Dr. Pamela Ohashi’s research into T-cell activation and boosting the immune system to fight tumors. Her work focuses on understanding the signaling pathways of T-cells to help activate, direct and enhance anti-tumor responses in cancer. Clinical trial of her team’s adoptive cell therapy will begin in the Fall of 2013.
- $5.2 million to purchase cutting edge research equipment and support breast cancer research activities in The Princess Margaret research expansion at MaRS (Medical and Related Science).
- $3 million to create The Weekend to End Breast Cancer Chair in Breast Cancer Research, held by Dr. Tak Mak, a world renowned cancer research scientist.
- $1.5 million to the Walker Innovation Program, which supports researchers and new ideas that have the potential for advancing scientific knowledge of breast cancer.
- $1.4 million to support Dr. Norman Boyd’s research into breast cancer prevention, focusing on the understanding of mammographic density as a risk factor.
- $1.8 million to support Mass Spectrometer program.
- $3.9 million toward a comprehensive breast imaging program and the purchase of a breast MRI and digital mammography machine.
- $3 million toward a newly revamped and re-designed M. Lau Breast Centre that provides complete care for breast cancer patients.
- $2.4 million to support clinical trials for breast cancer patients, and $500,000 for fellowship program.
- $2 million to support an extensive Tumour Bank, database maintenance and pathology renovations.
- $1.3 million to support Dr. David McCready’s rapid diagnosis pilot study, which is now The Gattuso Rapid Diagnostic Centre and sees up to 1500 patients a year.
- $550,000 to support the clinical trial of intraoperative radiation therapy, led by Dr. David McCready and Dr. Anthony Fyles.
- $250,000 toward the design and creation of the new Conway Chemotherapy and Transfusion Centre, the largest centre of its kind in North America.
- $550,000 to support the surgical robotics program for gynecological cancer patients.
- $160,000 toward the Familial Ovarian Cancer Clinic, which now also provides genetic counselling for breast cancer patients.
- $2.2 million for other clinical enhancements and genetics research programs.
- $9.4 million for the establishment and continued support of the first in-hospital Survivorship Clinic and Program in Canada. This includes ELLICSR, a 12,000-square-foot innovative research centre, led by Dr. Pamela Catton, and caringvoices.ca, an award- winning online community for survivors and their families.
- $1 million to provide reconstructive breast surgery for women who have had breast cancer.
PMC Foundation Fund
- $2.5 million to support the PMC Foundation Fund
*New cancer drug development is a long and risk- filled process. We are very encouraged by this discovery and reaching this major milestone. The drug discovery from Dr. Tak Mak and Dr. Dennis Slamon announced by The Princess Margaret Cancer Foundation in June has been cleared by Health Canada and is in the process of being cleared by the University Health Network Research Ethics Board before the clinical trials can begin later this year. When cleared, the drug will be listed at www.canadiancancertrials.ca
Conquering Cancer: A tour of The Princess Margaret highlighting how it is being done
Over 50,000 people have participated in the Shoppers Drug Mart Weekend to End Women's Cancers, and their individual contributions have added up to over $141 million raised. This tour of the Princess Margaret Cancer Centre highlights how those funds have made a difference in conquering cancer in our lifetime.